Screener
Lexicon Pharmaceuticals LXRX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $692K-97.6% | $21.1M+1,572% | $5.49M-79.3% | $14.18M+710% | $28.87M+1,653% | ||
| $39K+18.2% | $108K+260% | $201K-42.2% | $10K-85.9% | $33K-80.1% | ||
| $653K-97.7% | $20.99M+1,604% | $5.29M-79.8% | $14.17M+744% | $28.83M+1,847% | ||
| 94.4%-5.5pp | 99.5%+1.9pp | 96.3%-2.3pp | 99.9%+4.0pp | 99.9%+10.0pp | ||
| $17.44M+10.8% | $12.76M-16.6% | $11.32M-57.6% | $18.76M-27.2% | $15.75M-10.7% | ||
| $9.75M+4.3% | $9.23M-20.5% | $8.76M-72.9% | $7.6M-80.8% | $9.35M-76.1% | ||
| $27.23M+8.4% | $22.1M-18.0% | $20.27M-65.8% | $26.37M-59.7% | $25.13M-55.9% | ||
| -$26.54M-810% | -$996K+96.1% | -$14.78M+54.9% | -$12.19M+80.9% | $3.74M+107% | ||
| -3,835.3%-3,848pp | -4.7%+2,030pp | -269.1%-146pp | -85.9%+3,554pp | 12.9%+3,374pp | ||
| $1.13M-41.2% | $1.48M-50.2% | $1.69M-46.1% | $1.76M-46.5% | $1.92M-41.0% | ||
| $1.72M-6.1% | $1.54M-30.5% | $1.28M-54.7% | $1.57M-54.3% | $1.83M-55.7% | ||
| —— | —— | —— | —— | —— | ||
| -$31.78M-1,077% | -$1.04M+95.9% | -$15.53M+54.0% | -$12.77M+80.3% | $3.25M+106% | ||
| -4,591.8%-4,603pp | -4.9%+1,999pp | -282.7%-156pp | -90%+3,613pp | 11.3%+3,255pp | ||
| -$0.07-800% | $0.00+100% | -$0.04+55.6% | -$0.04+77.8% | $0.01+106% | ||
| -$26.44M-776% | -$886K+96.5% | -$14.66M+55.0% | -$12.04M+81.1% | $3.91M+107% | ||
| -3,820.5%-3,834pp | -4.2%+2,017pp | -266.9%-144pp | -84.9%+3,548pp | 13.6%+3,366pp | ||
| -$26.54M-810% | -$996K+96.1% | -$14.78M+54.9% | -$12.19M+80.9% | $3.74M+107% |
FAQ
- What is Lexicon Pharmaceuticals's revenue?
- Lexicon Pharmaceuticals (LXRX) generated $41.5M in revenue over the trailing twelve months, down 29.0% year over year.
- Is Lexicon Pharmaceuticals profitable?
- Lexicon Pharmaceuticals is not currently profitable: it reported a net loss of $61.1M over the trailing twelve months, a -147.4% net margin.
- What are Lexicon Pharmaceuticals's profit margins?
- Gross margin is 99.1% and operating margin is -131.4%, with a -147.4% net margin.
- What is Lexicon Pharmaceuticals's earnings per share?
- Lexicon Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.15.
- Where does Lexicon Pharmaceuticals's income statement data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
